文献速递腹部CT

多排CT用于进展期胃癌术前N分期:转移性淋巴结直径总和能否用于N分期评估

Preoperative N stage evaluation in advanced gastric cancer patients using multidetector CT: can the sum of the diameters of metastatic LNs be used for N stage evaluation?
PubMed 文献 · Clin Radiol · 2019-08-02

本研究连续纳入127例接受术前多排CT(MDCT)并行胃切除术的进展期胃癌患者,比较转移性淋巴结直径总和(LN-sum)与常规MDCT分期对淋巴结评估的诊断效能。LN-sum与病理N分期及转移淋巴结数目显著相关(rho=0.69、0.73,p<0.0001),在鉴别N0-2与N3时敏感度、准确率、PPV和NPV均显著高于常规MDCT分期。作者认为LN-sum可能对评估进展期胃癌N3分期足够有用,并可能有助于制定合适的治疗方案。

要点

  • MDCT检出转移性淋巴结总数显著少于组织病理学评估(p<0.0001)。
  • LN-sum与病理N分期及转移淋巴结数目显著相关(rho=0.69、0.73,p<0.0001)。
  • 鉴别N0-2与N3时LN-sum的敏感度、准确率、PPV、NPV均显著高于常规MDCT分期。

核心结论

  • LN-sum可能对评估进展期胃癌N3分期足够有用,并可能有助于为进展期胃癌患者制定合适的治疗。

研究设计与样本

  • 研究为连续纳入127例接受术前MDCT及胃切除术的进展期胃癌患者,比较LN-sum与常规MDCT分期的诊断效能。
  • MDCT上转移性淋巴结定义为短径≥8 mm、明显或不均匀强化、以及形态学特征(中央坏死、圆形、簇状聚集)。

关键影像表现/征象

  • MDCT上转移性淋巴结的定义包括短径≥8 mm、明显或不均匀强化、以及形态学特征(中央坏死、圆形、簇状聚集)。

诊断标准与关键数值

  • LN-sum鉴别N分期≥N2的AUC为0.896,cut-off值为12.5 mm。
  • LN-sum鉴别N3的AUC为0.835,cut-off值为23.5 mm。
  • 鉴别N0-2与N3时,LN-sum的敏感度80.4% vs 常规MDCT分期52.2%,准确率81.1% vs 68.5%,PPV 71.2% vs 57.1%,NPV 88% vs 74.1%,LN-sum均显著更高。

临床应用与阅片要点

  • 作者认为LN-sum可能对评估进展期胃癌N3分期足够有用,并可能有助于制定合适的治疗方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To compare the diagnostic performance of total counts of metastatic lymph nodes (LN-sum) and conventional multidetector (MD) computed tomography (CT) staging in the nodal evaluation of advanced gastric cancer (AGC) patients.

MATERIALS AND METHODS: In total, 127 consecutive patients who underwent preoperative MDCT and gastrectomy for AGC were identified. Metastatic LNs on MDCT were defined as LNs with a short axis ≥8 mm, marked or heterogeneous enhancement, and morphological features (central necrosis, round shape, clustering). The sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) of the N-stage using LN-sum and conventional MDCT staging were generated and compared. In addition, metastatic LN counts between the MDCT and the histopathological examinations and correlation between LN-sum and histopathological nodal status were analysed.

RESULTS: The total counts of metastatic LNs on MDCT was significantly smaller than those detected in histopathological assessments (p<0.0001). LN-sum showed significant correlation with the pathological N stage and the number of metastatic LNs (rho=0.69, 0.73, p<0.0001). The areas under the receiver operating characteristic curve were 0.896, and 0.835, for N stage ≥N2 and N3, with cut-off values of 12.5 and 23.5 mm, respectively. LN-sum provided better diagnostic performance than conventional MDCT staging for discriminating N0-2 versus N3; sensitivity, accuracy, PPV and NPV of LN-sum were significantly higher (80.4 versus 52.2%, 81.1 versus 68.5%, 71.2 versus 57.1%, and 88 versus 74.1%).

CONCLUSION: LN-sum may be sufficiently useful in assessing the N3 stage of AGC and may help to plan appropriate therapy for AGC patients.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. You JM, Kim TU, Kim S, et al. Preoperative N stage evaluation in advanced gastric cancer patients using multidetector CT: can the sum of the diameters of metastatic LNs be used for N stage evaluation? Clin Radiol. 2019. PMID: 31378300. doi:10.1016/j.crad.2019.06.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。